Achieve Life Sciences, Inc. (ACHV) Stock

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc. is led by CEO Richard A. Stewart, employs 25 people, headquartered in CA, publicly traded since 1995.

Achieve Life Sciences, Inc. (ACHV) stock trades at $6.49 with a market capitalization of $667.83M. The stock is valued at a negative price-to-earnings (P/E) ratio of -4.20, reflecting a net loss over the last twelve months, a negative price-to-book of -41.48, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.62 and $8.64, and currently trades 24.9% below its 52-week high.

On profitability, Achieve Life Sciences, Inc. generates a return on equity (ROE) of -892.07% (not meaningful, as shareholders' equity is negative), return on capital employed of 807.40%.

Achieve Life Sciences, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Achieve Life Sciences, Inc. reported revenue of $5.0M rising to $0, a change of -100.0% across 10 years. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-55.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-114.0M.

Borrowings stand at $15.0M, cash from operations was $-49.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged 383.3% over five years, and was -250.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Achieve Life Sciences, Inc. (ACHV) — frequently asked questions